{
  "company": {
    "name": "Myricx Bio",
    "website": "https://myricxbio.com/",
    "record": "https://startuphistory.org/c/myricxbio.com"
  },
  "status": null,
  "history_since": "2023-09-22T14:11:23.000Z",
  "baseline": {
    "snapshot_id": "e83e8fcf83be8267150090e2b277eae1ce77a827c3925131d4510fceec20ad94",
    "observed_at": "2023-09-22T14:11:23.000Z",
    "headline": "Developing a new class of ADCs based on NMT inhibition to treat cancer",
    "description": null,
    "evidence": "https://web.archive.org/web/20230922141123/https://myricxbio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:45:24.814Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T17:45:24.814Z",
      "variants": [
        {
          "headline": "Developing a new class of ADCs based on NMT inhibition to treat cancer",
          "subhead": null,
          "observed_at": "2023-09-22T14:11:23.000Z",
          "evidence": "https://web.archive.org/web/20230922141123/https://myricxbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the first class of ADCs based on NMT inhibition to treat cancer",
          "subhead": null,
          "observed_at": "2024-02-05T15:53:47.000Z",
          "evidence": "https://web.archive.org/web/20240205155347/https://myricxbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the first class of ADCs based on NMT inhibition to treat cancer",
          "subhead": null,
          "observed_at": "2024-07-08T22:01:01.000Z",
          "evidence": "https://web.archive.org/web/20240708220101/https://myricxbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the first class of ADCs based on NMT inhibition to treat cancer",
          "subhead": null,
          "observed_at": "2025-01-06T14:46:36.000Z",
          "evidence": "https://web.archive.org/web/20250106144636/https://myricxbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the first class of ADCs based on NMT inhibition to treat cancer",
          "subhead": null,
          "observed_at": "2025-09-23T22:37:00.000Z",
          "evidence": "https://web.archive.org/web/20250923223700/https://myricxbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the first class of ADCs based on NMT inhibition to treat cancer",
          "subhead": null,
          "observed_at": "2026-07-06T21:41:41.000Z",
          "evidence": "https://web.archive.org/web/20260706214141/https://myricxbio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the first class of ADCs based on NMT inhibition to treat cancer",
          "subhead": null,
          "observed_at": "2026-11-06T17:45:24.814Z",
          "evidence": "https://myricxbio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Developing the first class of ADCs based on NMT inhibition to treat cancer",
      "subhead": null,
      "from": "2023-09-22T14:11:23.000Z",
      "to": "2026-11-06T17:45:24.814Z",
      "captures": 7,
      "evidence": "https://myricxbio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2023-09-22T14:11:23.000Z",
          "to": "2026-11-06T17:45:24.814Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Myricx Bio” company record, https://startuphistory.org/c/myricxbio.com"
}